Table 2.
Correlation of serum Neu5Ac with clinical characteristics and severity of coronary lesions in ACS patients
| r | p | |
|---|---|---|
| Age (years) | 0.265 | 0.000 |
| Hypertension (%) | 0.262 | 0.000 |
| UA (μmol/L) | 0.312 | 0.000 |
| SCr (μmol/L) | 0.415 | 0.000 |
| HDL-C (mmol/L) | −0.187 | 0.000 |
| CK-MB (U/L) | 0.232 | 0.000 |
| Gensini score | 0.283 | 0.000 |
| FBG (mmol/L) | 0.039 | 0.282 |
| TC (mmol/L) | 0.048 | 0.200 |
| TG (mmol/L) | 0.023 | 0.545 |
| CRP (mg/L) | 0.052 | 0.171 |
| TnI (μg/L) | 0.044 | 0.224 |
Neu5Ac N-acetylneuraminic acid, ACS Acute coronary syndrome, UA Uric acid, SCr Serum creatinine, HDL-C High-density lipoprotein cholesterol, CK-MB MB isoform of creatine kinase, FBG Fasting blood glucose, TC Total cholesterol, TG Triglyceride, CRP C-reactive protein, TnI Troponin I